Managing hepatitis C in patients with the complications of cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|S1|14-20

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.S1, 2018-02, pp. : 14-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

AbstractDirect acting antivirals (DAA) have revolutionized the treatment of hepatitis C virus (HCV). Sustained virological response rates of nearly 100% have become common in the general population. However, physicians face the growing problem of managing HCV in patients with the complications of cirrhosis, eg hepatic decompensation or hepatocellular carcinoma (HCC). Safety and efficacy remain a clinical challenge in these difficult‐to‐treat patients. This review focuses on the current state of knowledge and treatment regimens in patients with decompensated cirrhosis as well as the potential risk of the development of HCC following DAA therapy.

Related content

Type 2 diabetes in hepatitis B cirrhosis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 591-599 (9)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of serum adiponectin level in the development of liver cirrhosis in patients with hepatitis C virus

By Latif Hatem  

Clinical and Experimental Medicine, Vol. 11, Iss. 2, 2011-06 ,pp. : 123-129 (7)

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1004-1012 (9)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations in the NS5A Gene Predict Response to Interferon Therapy in Japanese Patients with Chronic Hepatitis C and Cirrhosis

By Murashima Shiro   Ide Tatsuya   Miyajima Ichiro   Kumashiro Ryukichi   Ueno Takato   Sakisaka Shotaro   Sata Michio  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 1, 1999-05 ,pp. : 27-32 (6)

Informa Healthcare

Access to resources Recommend Favorite

Survivin–IgM in cirrhotic hepatitis C

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1008-1018 (11)

John Wiley & Sons Inc

Access to resources Recommend Favorite